Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Phoenix, Arizona 85014


Purpose:

The purpose of this study is to determine the safety and efficacy of an ocular sirolimus (rapamycin) formulation at various doses in patients with diabetic macular edema.


Criteria:

Inclusion Criteria include but are not limited to: - Diagnosed with diabetes mellitus - Macular edema secondary to diabetic retinopathy - Visual acuity of 20/40 to 20/200 in study eye Exclusion Criteria include but are not limited to: - Any other ocular disease that could compromise vision in the study eye - Any of the following treatments to the study eye within 90 days prior to study start: intravitreal injections; posterior subtenons steroids; focal/grid macular photocoagulation; intraocular surgery - Capsulotomy of the study eye within 30 days prior to study start


NCT ID:

NCT00656643


Primary Contact:

Study Director
Joel Naor, MD
MacuSight, Inc.


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85014
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.